Literature DB >> 3613864

Learning enhancement and behavioral arousal induced by yohimbine.

M S Huang, R B Messing, S B Sparber.   

Abstract

Learning of a food motivated delayed reinforcement autoshaping task was investigated in rats treated with water vehicle or the prototypical anxiogenic agent and alpha 2-adrenergic antagonist yohimbine (0.5 or 1.5 mg/kg, i.p. 30 min before behavioral testing). Unconditioned exploratory rearing activity was monitored concomitantly with acquisition of a lever touch response. The low dose of yohimbine enhanced learning, but it also increased unconditioned behavioral arousal. The high dose retarded acquisition, but when it was withdrawn the animals learned but exploratory activity increased beyond control levels prior to acquisition. Learning thus appeared to be related to the behavioral arousal produced by yohimbine, suggesting that learning enhancement by anxiogenic substances is not due to a direct effect on processes intrinsic to information storage and retrieval; rather, anxiogenic substances may be important modulators of vigilance and performance variables.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3613864     DOI: 10.1016/0024-3205(87)90625-4

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  4 in total

1.  Behavioural effects of the alpha 2-adrenoceptor antagonists idazoxan and yohimbine in rats: comparisons with amphetamine.

Authors:  D J Sanger
Journal:  Psychopharmacology (Berl)       Date:  1988       Impact factor: 4.530

2.  Proceedings of the British Pharmacological Society. Bristol, 5-7th April. Abstracts.

Authors: 
Journal:  Br J Pharmacol       Date:  1989-07       Impact factor: 8.739

3.  Proceedings of the British Pharmacological Society. London, 19th-21st December. Abstracts.

Authors: 
Journal:  Br J Pharmacol       Date:  1989-03       Impact factor: 8.739

4.  The alpha 2-adrenoceptor antagonists idazoxan and yohimbine increase rates of DRL responding in rats.

Authors:  D J Sanger
Journal:  Psychopharmacology (Berl)       Date:  1988       Impact factor: 4.530

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.